Joint Cancer Vanguards - Lead by the Royal Marsden NHS Foundation Trust Project Name: Developing best practice in biosimilar adoption and understanding Project period: 28th November 2016 - 1st April 2018
Joint working project summary:
The aim is to ensure biosimilars are used safely, with confidence in the right patients. This project will combine skills and resources to develop a targeted biosimilar education program applicable to any biosimilar to ensure their use is optimised in the NHS. Materials for both education and policy guidance will be developed, tested and shared with the wider NHS. Research will be conducted into healthcare professional attitudes towards biosimilars as well the impact of the education program. Further research will assess the impact of biosimilars on budget and service provision.
Expected patient outcomes for this project:
Improved knowledge of biosimilars will help healthcare professionals inform patients more fully, so they can make well considered decisions together;
Engaging with patient groups will lead to the development of patient focused materials to assist with patient engagement and decision making as well as potentially saving healthcare professional time;
Informed prescribing decisions and governance will help ensure biosimilar use is appropriate for patients;
Potential savings could be redirected to improve access to medicines as well as potentially improving the quality of care for patients due to increased investment in clinical practice.
Sandoz Contribution / Trust Contribution:
The contributions from both parties are on the basis of time, expertise and resources. There will be no direct financial contribution from either party to the other during this project.
The Royal Marsden will lead the NHS contribution including development of the deliverables, providing project management and coordinating contributions from each Cancer Vanguard Trust. Contributors will be a range of multidisciplinary professionals involved in biosimilar usage. In addition, the Vanguards will allow access to NHS staff for training purposes and provide training venues as well as leading on the sharing of findings to the wider NHS
Sandoz will partner with the Royal Marsden in providing overall project management and co-ordination and also contribute to the deliverables. Subject matter expertise and delivery of training will be provided by appropriately qualified Sandoz personnel and external experts. Sandoz will pay the fees and expenses of providing external speakers for training events